Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... 0.01). Fifty-four of 95 LAT patients (57%) and 81 of 131 non-LAT patients (62%) were on warfarin before TEE. The incidence of prior CVE in LAT patients without...
2009 NOV 16 ... the time of pulmonary vein isolation (PVI) is not known. Most centers stop administering warfarin (Coumadin) and use bridging with heparin or enoxaparin." "The purpose of ...
2009 NOV 23 ... Hematology, Rodenticide, Stroke, Therapy, Thromboembolism, Thrombosis, Treatment, Warfarin, University of Amsterdam. This article was prepared by Biotech Business ...
2009 NOV 9 ... (3) admission to a stroke unit; (4) carotid imaging; (5) antithrombotic therapy; and (6) warfarin for atrial fibrillation at discharge. were risk-adjusted stroke fatality, discharge ...
2009 NOV 16 ... of stroke, heart rate, incremental QRS prolongation (p=0.0418), and the absence of warfarin use. Patients with QRS prolongation >15 ms had a worse prognosis than those with QRS ...
2009 NOV 9 ... vs. 15.0%, P = .04), low-molecular-weight heparin (18.7% vs. 12.1%, P = .003), and warfarin (31.7% vs. 11.0%, P< .0001) for deep vein thrombosis prophylaxis in the orthopedic ...
2009 NOV 23 ... are common clinical problems in dialysis patients that prompt consideration of warfarin therapy. Atrial fibrillation appears to be more common in people with low glomerular ...
2009 NOV 9 ... lymphoma). Recurrence of VTE episodes and major and minor bleeding during treatment with warfarin or low molecular weight heparin (LMWH) were recorded. All 57 patients were initially ...
2009 NOV 23 ... in Birmingham, the United Kingdom report. "Anticoagulation with warfarin will reduce stroke risk by about two thirds. The main risks of anticoagulation, namely ...
2009 NOV 2 ... 2-part, 2-period crossover study assessed pharmacokinetics/pharmacodynamics of warfarin in the presence/absence of multiple-dose sitagliptin," researchers in the United States ...
2009 NOV 9 ... cardiomyopathy (p=0.002), less likely to be prescribed spironolactone (p=0.005) or warfarin (p=0.02), and less likely to have a widened QRS >120 ms (p=0.005). There was a high ...
2009 NOV 16 ... The use of fondaparinux as a bridging agent between direct thrombin inhibitor and warfarin therapy has been proposed. A recently published case report gives support to this ...
2009 NOV 16 ... epigenetic mechanisms. Specific examples from pharmacogenomics are described including warfarin dosage and prediction of abacavir hypersensitivity that illustrate how in some cases ...
2009 NOV 2 ... published in the journal Medical Clinics of North America, "The oral anticoagulant warfarin is a common medication that requires special consideration in the perioperative period. ...
2009 NOV 9 ... study was to investigate the time within target INR and safety profile of thrice weekly warfarin administration in haemodialysis patients with a clinical indication for anticoagulation ...
2009 NOV 23 ... 5 and 11 days prior to surgery, respectively. Four other patients were on regular warfarin therapy due to previous deep venous thrombosis, pulmonary embolism, or mechanical aortic ...
2009 NOV 9 ... According to recent research from the United States, "Interactions of warfarin with other drugs or substances can pose a serious problem. We assessed three drug ...
2009 NOV 23 ... compared with 23.5% for those >= 80 years of age. Vitamin K antagonists (VKAs) like warfarin have been shown to greatly reduce the risk of stroke. However, despite their proven ...
2009 NOV 2 ... Agent, Hematology, Heparin, Pharmaceuticals, Physiology, Therapy, Treatment, Warfarin Sodium, University of Virginia. This article was prepared by Biotech ...
